1.0
May 11, 2023
Recommend
CEO approval
Business Outlook
Pros
Interesting work with big pharma and mid-size biotech
Cons
Toxic culture top-down with leadership that only notices the bad things and puts all pressure on analysts; Unproductive professional development conversations that may help in the short-term, but fail to play out long-term; Colleagues that are all middle-class with no first gen or low-income individuals; Zero diversity
